BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1031 related articles for article (PubMed ID: 17270316)

  • 21. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vaccines against varicella-zoster virus (VZV)].
    Salleras L; Salleras M; Soldevila N; Prat A; Garrido P; Domínguez Á
    Enferm Infecc Microbiol Clin; 2015; 33(6):411-23. PubMed ID: 26096575
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults.
    Sanford M; Keating GM
    Drugs Aging; 2010 Feb; 27(2):159-76. PubMed ID: 20104941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella-zoster virus: pathogenesis, incidence patterns and vaccination programs.
    Gabutti G; Franchi M; Maniscalco L; Stefanati A
    Minerva Pediatr; 2016 Jun; 68(3):213-25. PubMed ID: 27125440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The burden of hospitalisation for varicella and herpes zoster in England from 2004 to 2013.
    Hobbelen PH; Stowe J; Amirthalingam G; Miller L; van Hoek AJ
    J Infect; 2016 Sep; 73(3):241-53. PubMed ID: 27283754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different vaccination strategies in Spain and its impact on severe varicella and zoster.
    Gil-Prieto R; Walter S; Gonzalez-Escalada A; Garcia-Garcia L; Marín-García P; Gil-de-Miguel A
    Vaccine; 2014 Jan; 32(2):277-83. PubMed ID: 24275483
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends in varicella and herpes zoster epidemiology before and after the implementation of universal one-dose varicella vaccination over one decade in South Korea, 2003-2015.
    Choi JK; Park SH; Park S; Choi SM; Kim SH; Lee DG; Yoo JH; Choi JH; Kang JH
    Hum Vaccin Immunother; 2019; 15(11):2554-2560. PubMed ID: 31008679
    [No Abstract]   [Full Text] [Related]  

  • 29. [Varicella vaccine].
    Abarca Villaseca K
    Rev Chilena Infectol; 2006 Mar; 23(1):56-9. PubMed ID: 16462966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Varicella vaccination: who should be vaccinated these days?].
    Hügle B; Suchowerskyj P; Schuster V
    MMW Fortschr Med; 2005 Feb; 147(8):31-2, 34-5. PubMed ID: 18441563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The incidence of varicella and herpes zoster in Massachusetts as measured by the Behavioral Risk Factor Surveillance System (BRFSS) during a period of increasing varicella vaccine coverage, 1998-2003.
    Yih WK; Brooks DR; Lett SM; Jumaan AO; Zhang Z; Clements KM; Seward JF
    BMC Public Health; 2005 Jun; 5():68. PubMed ID: 15960856
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Routine Varicella Immunization on the Epidemiology and Immunogenicity of Varicella and Shingles.
    Otani N; Shima M; Yamamoto T; Okuno T
    Viruses; 2022 Mar; 14(3):. PubMed ID: 35336994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Varicella Virus Vaccination in the United States.
    Shaw J; Gershon AA
    Viral Immunol; 2018 Mar; 31(2):96-103. PubMed ID: 29173081
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Trends in U.S. Community hospitalizations due to herpes zoster: 2001-2015.
    Pham MA; Bednarczyk RA; Becker ER; Orenstein WA; Omer SB
    Vaccine; 2019 Feb; 37(6):882-888. PubMed ID: 30616954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England.
    van Hoek AJ; Melegaro A; Zagheni E; Edmunds WJ; Gay N
    Vaccine; 2011 Mar; 29(13):2411-20. PubMed ID: 21277405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Varicella zoster virus vaccination policies and surveillance strategies in Europe.
    Pinot de Moira A; Nardone A;
    Euro Surveill; 2005 Jan; 10(1):43-5. PubMed ID: 15701939
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Varicella vaccination in Australia.
    Macartney KK; Beutels P; McIntyre P; Burgess MA
    J Paediatr Child Health; 2005 Nov; 41(11):544-52. PubMed ID: 16398834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.
    Gershon AA; Gershon MD; Shapiro ED
    J Infect Dis; 2021 Sep; 224(12 Suppl 2):S387-S397. PubMed ID: 34590140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.